Ryosuke Ishida, Xi Zeng, Nagomi Kurebayashi, Takashi Murayama, Shuichi Mori, Yuga Yamamoto, Hiroyuki Kagechika. Development of RyR2 inhibitors with a parabanic acid skeleton as the core structure RSC Medicinal Chemistry. 2025.04; ( DOI )

Ishida Ryosuke, Zeng Xi, Kurebayashi Nagomi, Maruyama Takashi, Mori Shuichi, Kagechika Hiroyuki. リアノジン受容体2阻害剤の発見と構造活性相関(Discovery and Structure-Activity Relationship of a Ryanodine Receptor 2 Inhibitor) Chemical & Pharmaceutical Bulletin. 2024.04; 72 (4): 399-407. ( 医中誌 )

Ishida R, Zeng X, Kurebayashi N, Murayama T, Mori S, Kagechika H. Discovery and Structure-Activity Relationship of a Ryanodine Receptor 2 Inhibitor. Chemical & pharmaceutical bulletin. 2024; 72 (4): 399-407. ( PubMed, DOI )

Ishida R, Kurebayashi N, Iinuma H, Zeng X, Mori S, Kodama M, Murayama T, Masuno H, Takeda F, Kawahata M, Tanatani A, Miura A, Nishio H, Sakurai T, Kagechika H. A potent and selective cis-amide inhibitor of ryanodine receptor 2 as a candidate for cardiac arrhythmia treatment. European journal of medicinal chemistry. 2023.12; 262 115910. ( PubMed, DOI )

Xi Zeng, Ryosuke Ishida, Nagomi Kurebayashi, Hiroto Iinuma, Masami Kodama, Takashi Murayama, Hiroyuki Kagechika. A potent and selective cis-amide inhibitor of ryanodine receptor 2 as a candidate for cardiac arrhythmia treatment. 24th Tetrahedron Symposium 2024.06.19 Montpellier, France

Xi Zeng, Ryosuke Ishida, Nagomi Kurebayashi, Murayama Takashi, Yuuga Yamamoto, Shuichi Mori, Hiroyuki Kagechika. Development of novel RyR2 selective inhibitor. The 7th International Symposium on Biomedical Engineering 2022.11.25

曾　希, 石田良典, 呉林なごみ, 村山　尚, 山本優雅, 森　修一, 影近弘之. 新規2型リアノジン受容体選択的阻害剤の開発. 日本薬学会第143年会 2023.03.28 北海道大学

曾 希, 石田良典, 呉林なごみ, 村山 尚, 山本優雅, 森 修一, 影近弘之. 不整脈を引き起こす変異型RyR2新規阻害剤の開発. 第66回日本薬学会関東支部大会 2022.09.17 横浜薬科大学